[Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation].
- DOI
- 10.26442/00403660.2022.07.201715
- Published
- 2022 Aug 12
- Container
- Terapevticheskii arkhiv
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.26442/00403660.2022.07.201715,
title = {[Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation].},
author = {Zyryanov SK and Dyakov IN and Aisanov ZR},
year = {2022},
journal = {Terapevticheskii arkhiv},
doi = {10.26442/00403660.2022.07.201715},
url = {https://doi.org/10.26442/00403660.2022.07.201715}
}RIS
TY - JOUR TI - [Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation]. AU - Zyryanov SK AU - Dyakov IN AU - Aisanov ZR PY - 2022 JO - Terapevticheskii arkhiv DO - 10.26442/00403660.2022.07.201715 UR - https://doi.org/10.26442/00403660.2022.07.201715 ER -
APA
SK, Z., IN, D., & ZR, A. (2022). [Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation].. Terapevticheskii arkhiv. https://doi.org/10.26442/00403660.2022.07.201715
Source records
- pubmed · retrieved 2026-09-26T02:24:30.619Z